| 000 | 01711 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517223050.0 | ||
| 264 | 0 | _c20190314 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1096-1186 | ||
| 024 | 7 |
_a10.1016/j.phrs.2018.06.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeber, Gregory J | |
| 245 | 0 | 0 |
_aAltered microRNA regulation of short chain fatty acid receptors in the hypertensive kidney is normalized with hydrogen sulfide supplementation. _h[electronic resource] |
| 260 |
_bPharmacological research _c08 2018 |
||
| 300 |
_a157-165 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDysbiosis |
| 650 | 0 | 4 |
_aFatty Acids, Volatile _xmetabolism |
| 650 | 0 | 4 |
_aGastrointestinal Microbiome _xdrug effects |
| 650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
| 650 | 0 | 4 |
_aHydrogen Sulfide _xmetabolism |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMicroRNAs _xgenetics |
| 650 | 0 | 4 |
_aMorpholines _xmetabolism |
| 650 | 0 | 4 |
_aOrganothiophosphorus Compounds _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aFoster, Jaleyea | |
| 700 | 1 | _aPushpakumar, Sathnur B | |
| 700 | 1 | _aSen, Utpal | |
| 773 | 0 |
_tPharmacological research _gvol. 134 _gp. 157-165 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.phrs.2018.06.012 _zAvailable from publisher's website |
| 999 |
_c28536737 _d28536737 |
||